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13 RGS19 up-regulates Nm23-H1/2 expression via stimulating multiple 
transcriptional factors 
LI Yuanjun, WONG, Y.H. 
Division of Life Science and the Biotechnology Research Institute, HKUST 
 
The Nm23 gene family is comprised of ten genes that are involved in a variety of physiological 
and pathological processes ranging from cell proliferation, differentiation, apoptosis, cell cycle 
regulation, tumorigenesis to metastasis. Nm23-H1 and H2 are the most widely studied 
isoforms due to their ability to suppress metastasis. Loss or reduced expression of Nm23-H1/2 
is often associated with aggressive metastatic potential in different types of tumors. 
Conversely, elevated expression of Nm23-H1/2 has been shown to suppress metastasis. We 
have recently shown that both Nm23-H1 and H2 are up-regulated by RGS19 (regulator of G-
protein signaling 19, a GTPase activating protein for Gαi/o and Gαq subunits) in multiple cell 
types. However, the mechanism involved in RGS19-induced transcriptional regulation of 
Nm23 remains unknown. By means of in silico comparison of promoter sequences and 
luciferase reporter assays, we showed that the transcription factor AP-1 might be involved in 
the up-regulation of Nm23-H1/2 by RGS19. Both transient and stable expressions of RGS19 in 
HEK293 cells are able to stimulate the pAP-1-luc reporter. Since Nm23-H1 and H2 do not 
appear to utilize identical signaling partners, we have identified sixteen amino acids on the 
exposed surfaces of Nm23-H1 that are different from H2. To examine if these residues are 
responsible for specific protein-protein interactions between Nm23-H1/2 and diverse binding 
partners, we have constructed seven mutants with double or triple mutations that may alter the 
specificity of signaling. These Nm23 mutants will be characterized for their ability to regulate 
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(Supervisor: Dr. Julian A Tanner, HKU) 
 
Normal fertility in human involves a highly orchestrated signal communication between the 
hypothalamic-pituitary-gonadal. The pulsatile release of Luteinizing Hormone (LH) from 
pituitary gland is the key element in this ”concerto” for the simulation of sex steroid hormones 
synthesis and the production of mature eggs. Specific alterations in LH pulsatile pattern are 
linked to hypothalamic dysfunction in female patient with anovulatory infertility - by knowing 
the information of this pattern, clinicians can decide whether the patient needs treatment with 
pituitary hormones. However, there is currently no clinical feasible test to assess LH pulsatility 
due to the need of frequent blood sampling in every 10 minutes for 8 hours, which requires 
dedicated experts to carry out antibody-based immunoassay and causes significant blood loss 
to the patient. Here we propose a novel diagnostic strategy by using an electrochemical 
aptamer-based point-of-care (POC) biosensing system to continuously monitor the LH 
concentration in the patient with infertility. Our LH aptamer is a single-stranded DNA 
sequence generated via an in vitro selection method which embedded counter-selection steps 
against FSH and hCG, two structural similar gonadotropins with LH, to avoid cross-reactions. 
The aptamer can be modified with methylene blue (MB) redox label and coated on the gold 
surface, which forms a system that can monitor LH-induced structural switching of the aptamer 
by determining electrochemical currents that are associated with the distance between the 
redox label and the electrode surface. This system has the potential to be further developed as a 
POC diagnostic tool for the infertile patient caused by LH defect and assist clinicians 
to ”personalized” treatment with hormonal therapy.   
 
 
 
 
 
